Глобальная карта > Инновации > East Asia > China > Shanghai > I-Mab Biopharma
I-Mab Biopharma icon
I-Mab Biopharma has developed TJM2, a neutralising antibody, as a treatment for patients suffering severe cases of the coronavirus infection.
Rankings by SemRush
Национальный рейтинг
20th
in China
Региональный рейтинг
47th
in East Asia
Глобальный рейтинг
1124th
worldwide
Loading startups...